Author

Yashvi Hemani

Johns Hopkins University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdulmuez Abdulmalik· 1 shared Alexander Joseph AmbinderiD· 1 shared Amy Elizabeth DezerniD· 1 shared Bogdan C. Paun· 1 shared Brandy N. Perkins· 1 shared C. Conover TalbotiD· 1 shared Chen Lossos· 1 shared Christopher Esteb· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdulmuez Abdulmalik

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53

Nour Sabiha Naji, Sergiu Paşca, Theodora Chatzilygeroudi, Pablo Toledano-Sanz, Joseph Cataquiz Rimando, Yashvi Hemani, Brandy N. Perkins, Xinghan Zeng, C. Conover Talbot, Bogdan C. Paun, Abdulmuez Abdulmalik, Chen Lossos, Tatianna R. Boronina, Ilias Sinanidis, Panagiotis Tsakiroglou, , Theodoros Karantanos

This study identifies CCRL2 as a driver of IFN-γ signaling in TP53-mutated AML with erythroid differentiation, linking it to disease progression and poor outcomes.

bioRxiv · Feb 21, 2025 · PreprintCancer Biology